Molecule
Glimihar-MV1 is a combination of three active pharmaceutical ingredients:
- Glimepiride (1 mg): A sulfonylurea that stimulates insulin secretion from pancreatic beta cells, aiding in blood sugar regulation.
- Metformin SR (500 mg): A biguanide that reduces hepatic glucose production and improves insulin sensitivity, enhancing glucose uptake.
- Voglibose (0.2 mg): An alpha-glucosidase inhibitor that slows carbohydrate absorption in the intestines, preventing post-prandial blood glucose levels.
Category
Anti-Diabetic Medication – 3rd gen SU+Biguanide+Alpha-glucosidase inhibitor.
Glimepiride 1 mg + Metformin Hydrochloride 500 mg SR + Voglibose 0.2 mg
Glimihar-MV1 is a triple-combination oral hypoglycemic agent formulated with Glimepiride (1 mg), Metformin Hydrochloride (500 mg SR), and Voglibose (0.2 mg). This powerful blend helps improve glycemic control in Type 2 Diabetes Mellitus patients by stimulating insulin secretion, reducing hepatic glucose production, and delaying carbohydrate digestion.
Benefits
✔ Better blood sugar regulation
✔ Enhances insulin sensitivity
✔ Sustained glucose control
Storage & Precautions
- Store below 30°C, away from moisture
- Not for patients with severe renal or hepatic issues
- Avoid alcohol consumption
Packaging
10 x 10 Tablets per box
For medical use only. Consult a doctor before use.